Evidence map›Paper›PMID 33429926›Full record

ArticleMarine drugs2021

Synergistic Effect of Biosynthesized Silver Nanoparticles and Natural Phenolic Compounds against Drug-Resistant Fish Pathogens and Their Cytotoxicity: An In Vitro Study.

Ehab Essawy, Mohamed S Abdelfattah, Mansour El-Matbouli, Mona Saleh

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Biogenic synthesis of silver nanoparticle byFrontiers in microbiology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Ehab EssawyClinical Division of Fish Medicine, University of Veterinary Medicine, 1210 Vienna, Austria.
Mohamed S AbdelfattahDepartment of Chemistry, Faculty of Science, Helwan University, Cairo 11795, Egypt.ORCID 0000-0001-8148-0218
Mansour El-MatbouliClinical Division of Fish Medicine, University of Veterinary Medicine, 1210 Vienna, Austria.
Mona SalehClinical Division of Fish Medicine, University of Veterinary Medicine, 1210 Vienna, Austria.
University of Veterinary Medicine Vienna · ATHelwan University · EG

Funding

Austrian Science Fund P 32340-B
6 · The paper itself

Abstract

Fish pathogens causing disease outbreaks represent a major threat to aquaculture industry and food security. The aim of the presented study is to develop safe and effective bioactive agents against two bacterial isolates:

Indexed as

Metal NanoparticlesActinobacteriaAeromonas hydrophilaAnimalsAnti-Bacterial AgentsCell Line, TumorDrug Resistance, BacterialDrug SynergismFish DiseasesMicrobial Sensitivity TestsParticle SizePhenolsPseudomonas fluorescensRutaSilverAnti-Bacterial AgentsPhenolsSilverAgNPsEPCfish pathogensheliomycinrutinsynergistic effect

Identifiers

PMID33429926
PMCPMC7827678
OpenAlexW3120012235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.